Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients.

abstract：: Objective: To examine the role of Guanfacine Extended Release (GXR) in the management of behavioral disturbances in patients with Prader-Willi Syndrome (PWS). Methods: Twenty from a total of 27 individuals with genetically conf...

journal_title：Journal of child and adolescent psychopharmacology

authors： Singh D,Wakimoto Y,Filangieri C,Pinkhasov A,Angulo M

更新日期：2019-05-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to investigate the link between the use of specific types of substances and suicidality in adolescent inpatients with schizophrenia and schizoaffective disorder. METHODS:We performed a 10-year naturalistic retrospective study of 178 adolescent inpatients diagnosed as suffering from ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Shoval G,Sever J,Sher L,Diller R,Apter A,Weizman A,Zalsman G

更新日期：2006-12-01 00:00:00

abstract：OBJECTIVES:Studies have primarily focused on adverse life events (ALEs) as potential causes rather than as outcomes of pediatric depression. The current study prospectively examines ALEs in a sample of youth with attention-deficit/hyperactivity disorders (ADHD) to determine whether having a major depressive disorder (M...

journal_title：Journal of child and adolescent psychopharmacology

authors： Daviss WB,Diler R

更新日期：2012-02-01 00:00:00

abstract：INTRODUCTION:This study compared two atomoxetine titration dosing schedules and two atomoxetine maintenance doses for treating adolescent attention-deficit/hyperactivity disorder (ADHD) inattention and hyperactivity/impulsivity. METHODS:Adolescents (N = 267) were randomized to a slow or fast titration schedule. Patien...

journal_title：Journal of child and adolescent psychopharmacology

authors： Wietecha LA,Williams DW,Herbert M,Melmed RD,Greenbaum M,Schuh K

更新日期：2009-12-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to summarize results of a blinded review of potential suicidal events and analyses comparing incidence rates between paroxetine- and placebo-treated pediatric patients. METHOD:One thousand one hundred ninety-one (1191) children and adolescents received paroxetine (n = 642) or placeb...

journal_title：Journal of child and adolescent psychopharmacology

authors： Apter A,Lipschitz A,Fong R,Carpenter DJ,Krulewicz S,Davies JT,Wilkinson C,Perera P,Metz A

更新日期：2006-02-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to compare the pharmacokinetics of immediate-release methylphenidate (MPH) in preschool and school-aged children with attention-deficit/hyperactivity disorder (ADHD). METHODS:Preschool children 4-5 years (n = 14) and school-aged children 6-8 years (n = 9) with diagnoses of ADHD were...

journal_title：Journal of child and adolescent psychopharmacology

authors： Wigal SB,Gupta S,Greenhill L,Posner K,Lerner M,Steinhoff K,Wigal T,Kapelinski A,Martinez J,Modi NB,Stehli A,Swanson J

更新日期：2007-04-01 00:00:00

abstract：:Data on risperidone's efficacy and tolerability in adolescents with schizophrenia are scarce. We found only one prospective, open-label study in this population. The aim of this open-label, prospective study was to estimate the effectiveness, safety, and tolerability of risperidone treatment in adolescents with first-...

journal_title：Journal of child and adolescent psychopharmacology

authors： Zalsman G,Carmon E,Martin A,Bensason D,Weizman A,Tyano S

更新日期：2003-10-01 00:00:00

abstract：:ABSTRACT Neuroleptic malignant syndrome (NMS) is a potentially fatal disorder associated with the use of neuroleptics. Clinical research on NMS to date has focused exclusively on adults, but increasing numbers of juvenile cases have been reported. Two cases of juvenile NMS treated by the authors are discussed to demon...

journal_title：Journal of child and adolescent psychopharmacology

authors： Latz SR,McCracken JT

更新日期：1992-07-01 00:00:00

abstract：OBJECTIVE:The present study examined the course of ADHD over 24 months in a preschool population. METHOD:n=48 preschoolers with ADHD, aged 3.0-5.11 years, subjects included in a larger sample of preschoolers with depression and other disorders (n=306) were comprehensively assessed at 3 annual time points over 24 month...

journal_title：Journal of child and adolescent psychopharmacology

authors： Tandon M,Si X,Luby J

更新日期：2011-08-01 00:00:00

abstract：:Low concentrations of the neurotransmitter serotonin and its 5-hydroxyindoleacetic acid metabolite in the central nervous system have been associated with increased aggressive behavior in animals and humans. Controlled clinical trials of serotonin agonists in depressed adults have suggested that aggressive behavior is...

journal_title：Journal of child and adolescent psychopharmacology

authors： Constantino JN,Liberman M,Kincaid M

更新日期：1997-04-01 00:00:00

abstract：:Atomoxetine and stimulants have both been demonstrated effective as single agents for treatment of attention deficit hyperactivity disorder in children, adolescents, and adults. However, attention deficit hyperactivity disorder symptoms in some patients do not respond adequately to single-agent treatment with these me...

journal_title：Journal of child and adolescent psychopharmacology

authors： Brown TE

更新日期：2004-04-01 00:00:00

abstract：PURPOSE:Amantadine has a growing body of evidence for the treatment of aggressive behavior in patients with traumatic brain injury, autism spectrum disorder, and developmental disability. We describe our experience with adjunctive amantadine treatment for aggressive behavior in eight hospitalized children. METHODS:We ...

journal_title：Journal of child and adolescent psychopharmacology

authors： McGrane IR,Loveland JG,Zaluski HJ

更新日期：2016-12-01 00:00:00

abstract：OBJECTIVE:This study examined the effects of pediatric anxiety and its interaction with gender on reward processes. Based on the purported greater sensitivity to risk in females than males and the propensity for risk aversion in anxiety, clinical anxiety and female gender were hypothesized to act synergistically in red...

journal_title：Journal of child and adolescent psychopharmacology

authors： Dorfman J,Rosen D,Pine D,Ernst M

更新日期：2016-05-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to examine immediate-release methylphenidate effectiveness during the 10-month open-label continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment Study (PATS). METHODS:One hundred and forty preschoolers with ADHD, who had improved with a...

journal_title：Journal of child and adolescent psychopharmacology

authors： Vitiello B,Abikoff HB,Chuang SZ,Kollins SH,McCracken JT,Riddle MA,Swanson JM,Wigal T,McGough JJ,Ghuman JK,Wigal SB,Skrobala AM,Davies M,Posner K,Cunningham C,Greenhill LL

更新日期：2007-10-01 00:00:00

abstract：:In the United States, the novel compound duloxetine has been approved for the treatment of major depressive disorder (MDD) and diabetic peripheral neuropathic pain in the adult population. There are currently no published data on the use of duloxetine in children and adolescents. This report describes the successful t...

journal_title：Journal of child and adolescent psychopharmacology

authors： Meighen KG

更新日期：2007-02-01 00:00:00

abstract：:The prevalence and treatment of behavioral and mental illnesses in the adolescent population are increasing, and many of the medications used are continued into adulthood. Increased vigilance is necessary when caring for this population to prevent side effects and drug interactions. In this short communication, we pre...

journal_title：Journal of child and adolescent psychopharmacology

authors： George AK,Kunwar AR,Awasthi A

更新日期：2005-08-01 00:00:00

abstract：BACKGROUND:The use of atypical antipsychotics is increasing in adolescent populations, but little is known about adherence with these treatments. This study examined postdischarge adherence of adolescents treated as inpatients with either olanzapine or risperidone. METHODS:Eighty-six (86) adolescent inpatients (43 per...

journal_title：Journal of child and adolescent psychopharmacology

authors： Pogge DL,Singer MB,Harvey PD

更新日期：2005-12-01 00:00:00

abstract：OBJECTIVE:Tourette syndrome (TS) is a neuropsychiatric disorder associated with motor and vocal tics. Some people with TS have reported using alternative or complementary medicine (CAM), including nutritional supplements to control their tics. In a recent national survey, approximately 40% of people reported having use...

journal_title：Journal of child and adolescent psychopharmacology

authors： Mantel BJ,Meyers A,Tran QY,Rogers S,Jacobson JS

更新日期：2004-01-01 00:00:00

abstract：OBJECTIVE:Psychostimulants are effective treatments for attention-deficit/hyperactivity disorder (ADHD) but may be associated with euphoric effects, misuse/diversion, and adverse effects. These risks are perceived by some clinicians to be greater in substance-abusing adolescents relative to non-substance-abusing adults...

journal_title：Journal of child and adolescent psychopharmacology

authors： Winhusen TM,Lewis DF,Riggs PD,Davies RD,Adler LA,Sonne S,Somoza EC

更新日期：2011-10-01 00:00:00

abstract：: Objective: To guide clinicians in selecting the "next line" selective serotonin reuptake inhibitor (SSRI) for adolescents with treatment-resistant major depressive disorder, we sought to compare response rates among SSRIs in the Treatment of SSRI-Resistant Depression in Ad...

journal_title：Journal of child and adolescent psychopharmacology

authors： Strawn JR,Mills JA,Croarkin PE

更新日期：2019-05-01 00:00:00

abstract：:Bipolar Disorders (BD) are often comorbid with disruptive behaviour disorders (DBDs) (oppositional-defiant disorder or conduct disorder), with negative implications on treatment strategy and outcome. The aim of this study was to assess the efficacy of quetiapine monotherapy in adolescents with BD comorbid with conduct...

journal_title：Journal of child and adolescent psychopharmacology

authors： Masi G,Pisano S,Pfanner C,Milone A,Manfredi A

更新日期：2013-10-01 00:00:00

abstract：BACKGROUND:Weight gain due to the use of second-generation antipsychotics is a major health care issue for adult and paediatric psychiatric patients. Little is known about long-term weight gain effects of aripiprazole compared to risperidone in children and adolescents. OBJECTIVE:The primary aim of this study is to as...

journal_title：Journal of child and adolescent psychopharmacology

authors： Schoemakers RJ,van Kesteren C,van Rosmalen J,Eussen MLJM,Dieleman HG,Beex-Oosterhuis MM

更新日期：2019-04-01 00:00:00

abstract：BACKGROUND:Recent evidence indicates that atypical antipsychotics represent a promising option for the treatment of autistic disorder. In particular, risperidone appears to be effective in treating aggressiveness, hyperactivity, irritability, stereotypies, social withdrawal, and lack of interests. OBJECTIVE:The aim of...

journal_title：Journal of child and adolescent psychopharmacology

authors： Gagliano A,Germanò E,Pustorino G,Impallomeni C,D'Arrigo C,Calamoneri F,Spina E

更新日期：2004-04-01 00:00:00

abstract：OBJECTIVE:Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) formulation consisting of uniform, dual-layered microbeads with an inner drug-loaded core. DR/ER-MPH is designed to delay the initial release of drug by 8-10 hours, and thereafter, provide a controlled, extended drug re...

journal_title：Journal of child and adolescent psychopharmacology

authors： Pliszka SR,Wilens TE,Bostrom S,Arnold VK,Marraffino A,Cutler AJ,López FA,DeSousa NJ,Sallee FR,Incledon B,Newcorn JH

更新日期：2017-08-01 00:00:00

abstract：:In clinical samples, juvenile bipolar disorder (JBPD) is frequently accompanied by co-morbid attention-deficit/hyperactivity disorder (ADHD). Clinical trials assessing combined psychopharmacological interventions in this population are scarce, and methylphenidate (MPH) may worsen manic symptoms. We conducted a randomi...

journal_title：Journal of child and adolescent psychopharmacology

authors： Zeni CP,Tramontina S,Ketzer CR,Pheula GF,Rohde LA

更新日期：2009-10-01 00:00:00

abstract：BACKGROUND:Despite its high chronicity, few studies have evaluated the effectiveness of long-term treatment for pediatric obsessive-compulsive disorder (OCD). The goal of the current analysis is to evaluate remission among children and adolescents with OCD treated with sertraline for 12 months. METHODS:Children (6-12 ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Wagner KD,Cook EH,Chung H,Messig M

更新日期：2003-01-01 00:00:00

abstract：:This study examined the contributions of childhood symptom dimensions and aspects of methylphenidate (MPH) treatment to the prediction of young adult outcomes in boys who were referred to a child psychiatry outpatient clinic. They were diagnosed with hyperkinetic reaction of childhood/minimal brain dysfunction, and gi...

journal_title：Journal of child and adolescent psychopharmacology

authors： Paternite CE,Loney J,Salisbury H,Whaley MA

更新日期：1999-01-01 00:00:00

abstract：:The increasing use of olanzapine for treating adolescent patients has brought with it greater awareness of the recognized side effects of this medication, especially weight gain. Of the reports of glucose dysregulation related to olanzapine therapy, only a few pertain to adolescents. We present five cases: two youths ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Bloch Y,Vardi O,Mendlovic S,Levkovitz Y,Gothelf D,Ratzoni G

更新日期：2003-04-01 00:00:00

abstract：:Bipolar disorder (BP) in youth is an impairing psychiatric disorder associated with high rates of relapse and recurrence. High rates of psychiatric and medical co-morbidities account for additional illness burden in pediatric BP. The elevated risk of overweight and obesity in this population is of particular concern. ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Goldstein TR,Goldstein BI,Mantz MB,Bailey B,Douaihy A

更新日期：2011-06-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to evaluate the efficacy and safety of acute quetiapine monotherapy in adolescents with schizophrenia. METHODS:Patients ages 13-17 years with an American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR) diagnosis ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Findling RL,McKenna K,Earley WR,Stankowski J,Pathak S

更新日期：2012-10-01 00:00:00